Surgeon General Regina Benjamin, MD, recently announced her resignation as the nation’s top doctor after four years in the post.
Dr. Benjamin, the 18th surgeon general, has been an active advocate for public health with a special interest in disease prevention, smoking cessation and healthy lifestyles.
“She has been a remarkable advocate in promoting the value of prevention as a national health priority. She forged the way as leader of the National Prevention Council, created under the Affordable Care Act, to help transform our nation’s health system from one that focuses on treating disease to one that focuses on prevention and staying well,” said Research!America Board member and American Public Health Association Executive Director Georges Benjamin, MD, in a press release.
Deputy Surgeon General Boris Lushniak, MD, MPH, will serve as acting Surgeon General in July while a permanent replacement is sought.
A lab-turned-hospital for mice in Boston is helping researchers understand cancer in humans.
Maybe this sounds like the opening line to one of those wasteful-spending reports, but it’s not. And the results — while still a long way from producing a treatment — have allowed researchers to gain insight into the links between cancer and a handful of mutated genes.
New York Times reporter Gina Kolkata describes the “hospital” at Beth Israel Deaconess Medical Center: imaging devices writ small with a dedicated pharmacy and clinical lab. She follows researchers that are looking into prostate cancer.
Mice are injected with a few rogue genes, and researchers monitor any tumors that develop. Initial treatment is similar to what humans in the same situation could expect; even the expected complications are the same. As in humans, the standard treatment works for only so long before the tumors begin resisting. Continue reading →
New National Public Opinion Poll Shows Majority of Americans Would Participate in Clinical Trials if Recommended by Their Doctor
Only Small Percentage say Health Care Professionals Have Ever Talked to Them about Medical Research
ALEXANDRIA, Va.-June 12, 2013 – More than two-thirds (72%) of Americans say it’s likely they would participate in a clinical trial if recommended by their doctor, but only 22% say a doctor or other health care professional has ever talked to them about medical research, according to a new national public opinion poll commissioned by Research!America. A wide majority (80%) say they have heard of a clinical trial – more than half (53%) through the Internet and only 24% from a doctor or other health care provider.
Only 16% of those polled say they or someone in their family have ever participated in clinical trials. Respondents believe individuals don’t participate because of a lack of awareness (53%), a lack of trust (53%), concerns that it’s too risky (51%), adverse health outcomes (44%), little or no monetary compensation (35%), privacy concerns (27%), and worries that it takes too much time (27%).
The findings point to the important role of health care providers in talking to their patients about clinical trials. “It is critical for providers and health systems in the U.S. to recognize the importance of generating knowledge about which treatments are best through participation in clinical trials,” said Robert Califf, MD, vice chancellor of clinical and translational research at Duke University Medical Center and board chair of the Clinical Research Forum, a co-sponsor of the poll. “Advances in common diseases like Alzheimer’s and diabetes, as well as rare diseases, depend on physicians and other members of the health care team offering their patients a chance to participate in clinical trials.” Continue reading →
The International Mental Health Research Organization is inviting you to submit essays about neuropsychiatric research and national mental health policy for their 2013 Brainstorm Contest. The best essay will snag the author two tickets to the IMHRO’s Music Festival for Mental Health. These tickets get you entry to the scientific symposium, reception, concert and dinner at the Staglin Family Vineyard on September 7, 2013. Continue reading →
Chartered in 2008, UAW Local 5810 represents over 6,000 postdoctoral scholars at the University of California, or approximately one tenth of all postdocs nationwide. Our members work at the cutting edge of the most sophisticated research in the world in a wide variety of health-related fields and beyond, and their contributions and discoveries move society forward in important ways.
The contract that our union negotiated with the University of California in 2010 includes a minimum salary scale that matches the NIH/NRSA scale, a stable and comprehensive benefits plan, more job security, and the right to career development resources. With the increases we’ve won in paid time off, female postdocs no longer have to face uncertain maternity leave. And when work-related issues arise, there is an impartial process for resolving them. When postdocs have an equal say in determining our working conditions, our quality of life improves, which in turn improves the quality of research. Continue reading →
Men’s Health Month increases the awareness of preventable health problems and encourages early detection and treatment of disease among males. According to MensHealthMonth.org, this is a time for health care providers, policy makers, the media, and individuals to encourage men to seek regular medical advice and early treatment for disease and injury. Continue reading →
Research!America is pleased to announce an exciting new program to introduce and engage early-career scientists in research advocacy and science policy. The 2013 Research!America Advocacy Academy is a unique opportunity for postdoctoral fellows in the health and biomedical sciences to learn about how to best incorporate advocacy and effective communications into their role as a scientist.
The 2013 class of up to 12 Research!America advocates will participate in a two-day Washington, DC, program from September 11-12, 2013. Participants will learn about the federal budget and appropriations process, tools for effective science communication and outreach as well as how to engage with elected representatives on scientific and research issues. The program includes visiting Capitol Hill to meet with policy makers and congressional staff members, providing participants with a first-hand experience advocating for health research. Rounding out this unique Washington experience, participants will attend Research!America’s National Health Research Forum where top leaders in government, industry, academia and patient organizations engage in moderated conversations on issues of importance to the research ecosystem. Continue reading →